nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—CLK3—endocrine gland—appendix cancer	0.00569	0.00569	CbGeAlD
Bosutinib—BMPR2—smooth muscle tissue—appendix cancer	0.00567	0.00567	CbGeAlD
Bosutinib—HIPK4—endocrine gland—appendix cancer	0.00563	0.00563	CbGeAlD
Bosutinib—TNIK—female gonad—appendix cancer	0.00563	0.00563	CbGeAlD
Bosutinib—SYK—female gonad—appendix cancer	0.00563	0.00563	CbGeAlD
Bosutinib—CDK2—female gonad—appendix cancer	0.00557	0.00557	CbGeAlD
Bosutinib—PHKG1—endocrine gland—appendix cancer	0.00557	0.00557	CbGeAlD
Bosutinib—STK26—female gonad—appendix cancer	0.00552	0.00552	CbGeAlD
Bosutinib—MAP2K1—epithelium—appendix cancer	0.00547	0.00547	CbGeAlD
Bosutinib—MAP4K4—smooth muscle tissue—appendix cancer	0.00546	0.00546	CbGeAlD
Bosutinib—TXK—endocrine gland—appendix cancer	0.00539	0.00539	CbGeAlD
Bosutinib—CHEK2—female gonad—appendix cancer	0.00533	0.00533	CbGeAlD
Bosutinib—WEE1—female gonad—appendix cancer	0.00529	0.00529	CbGeAlD
Bosutinib—DMPK—female gonad—appendix cancer	0.00529	0.00529	CbGeAlD
Bosutinib—MAP2K1—smooth muscle tissue—appendix cancer	0.00527	0.00527	CbGeAlD
Bosutinib—CSK—smooth muscle tissue—appendix cancer	0.00524	0.00524	CbGeAlD
Bosutinib—SYK—endocrine gland—appendix cancer	0.00523	0.00523	CbGeAlD
Bosutinib—CSNK1A1—smooth muscle tissue—appendix cancer	0.0052	0.0052	CbGeAlD
Bosutinib—CDK2—endocrine gland—appendix cancer	0.00518	0.00518	CbGeAlD
Bosutinib—STK26—endocrine gland—appendix cancer	0.00514	0.00514	CbGeAlD
Bosutinib—STK25—female gonad—appendix cancer	0.00505	0.00505	CbGeAlD
Bosutinib—WEE1—endocrine gland—appendix cancer	0.00492	0.00492	CbGeAlD
Bosutinib—DMPK—endocrine gland—appendix cancer	0.00492	0.00492	CbGeAlD
Bosutinib—PLK2—female gonad—appendix cancer	0.00491	0.00491	CbGeAlD
Bosutinib—PTK2B—smooth muscle tissue—appendix cancer	0.0049	0.0049	CbGeAlD
Bosutinib—SIK3—female gonad—appendix cancer	0.00488	0.00488	CbGeAlD
Bosutinib—ERBB3—epithelium—appendix cancer	0.00483	0.00483	CbGeAlD
Bosutinib—STK25—endocrine gland—appendix cancer	0.0047	0.0047	CbGeAlD
Bosutinib—STK4—female gonad—appendix cancer	0.0047	0.0047	CbGeAlD
Bosutinib—PTK2—epithelium—appendix cancer	0.00468	0.00468	CbGeAlD
Bosutinib—CAMK1D—female gonad—appendix cancer	0.00464	0.00464	CbGeAlD
Bosutinib—MAP2K2—smooth muscle tissue—appendix cancer	0.00464	0.00464	CbGeAlD
Bosutinib—STK24—female gonad—appendix cancer	0.00459	0.00459	CbGeAlD
Bosutinib—PLK2—endocrine gland—appendix cancer	0.00457	0.00457	CbGeAlD
Bosutinib—MAP3K7—smooth muscle tissue—appendix cancer	0.00456	0.00456	CbGeAlD
Bosutinib—SIK3—endocrine gland—appendix cancer	0.00454	0.00454	CbGeAlD
Bosutinib—PTK2—smooth muscle tissue—appendix cancer	0.00451	0.00451	CbGeAlD
Bosutinib—RPS6KB1—epithelium—appendix cancer	0.0045	0.0045	CbGeAlD
Bosutinib—FER—female gonad—appendix cancer	0.00444	0.00444	CbGeAlD
Bosutinib—TYRO3—female gonad—appendix cancer	0.00444	0.00444	CbGeAlD
Bosutinib—IRAK1—smooth muscle tissue—appendix cancer	0.00442	0.00442	CbGeAlD
Bosutinib—STK4—endocrine gland—appendix cancer	0.00437	0.00437	CbGeAlD
Bosutinib—RPS6KB1—smooth muscle tissue—appendix cancer	0.00434	0.00434	CbGeAlD
Bosutinib—BTK—female gonad—appendix cancer	0.00433	0.00433	CbGeAlD
Bosutinib—CAMK1D—endocrine gland—appendix cancer	0.00432	0.00432	CbGeAlD
Bosutinib—AXL—smooth muscle tissue—appendix cancer	0.0043	0.0043	CbGeAlD
Bosutinib—TNK2—female gonad—appendix cancer	0.00426	0.00426	CbGeAlD
Bosutinib—EPHB4—epithelium—appendix cancer	0.00426	0.00426	CbGeAlD
Bosutinib—TLK1—lymph node—appendix cancer	0.00425	0.00425	CbGeAlD
Bosutinib—MAP4K2—female gonad—appendix cancer	0.0042	0.0042	CbGeAlD
Bosutinib—PRKCQ—lymph node—appendix cancer	0.00419	0.00419	CbGeAlD
Bosutinib—EPHA2—epithelium—appendix cancer	0.00418	0.00418	CbGeAlD
Bosutinib—STK3—female gonad—appendix cancer	0.00415	0.00415	CbGeAlD
Bosutinib—FER—endocrine gland—appendix cancer	0.00413	0.00413	CbGeAlD
Bosutinib—TYRO3—endocrine gland—appendix cancer	0.00413	0.00413	CbGeAlD
Bosutinib—EPHA5—endocrine gland—appendix cancer	0.00413	0.00413	CbGeAlD
Bosutinib—ALK—endocrine gland—appendix cancer	0.00413	0.00413	CbGeAlD
Bosutinib—LYN—endocrine gland—appendix cancer	0.00411	0.00411	CbGeAlD
Bosutinib—EPHB4—smooth muscle tissue—appendix cancer	0.00411	0.00411	CbGeAlD
Bosutinib—ROCK1—female gonad—appendix cancer	0.00409	0.00409	CbGeAlD
Bosutinib—FYN—smooth muscle tissue—appendix cancer	0.00402	0.00402	CbGeAlD
Bosutinib—BMPR2—female gonad—appendix cancer	0.00398	0.00398	CbGeAlD
Bosutinib—TNK2—endocrine gland—appendix cancer	0.00397	0.00397	CbGeAlD
Bosutinib—EPHB3—female gonad—appendix cancer	0.00395	0.00395	CbGeAlD
Bosutinib—STK36—female gonad—appendix cancer	0.00395	0.00395	CbGeAlD
Bosutinib—DSTYK—lymph node—appendix cancer	0.00394	0.00394	CbGeAlD
Bosutinib—BMX—lymph node—appendix cancer	0.00394	0.00394	CbGeAlD
Bosutinib—CLK3—lymph node—appendix cancer	0.00394	0.00394	CbGeAlD
Bosutinib—MAP4K5—smooth muscle tissue—appendix cancer	0.00393	0.00393	CbGeAlD
Bosutinib—MAP4K2—endocrine gland—appendix cancer	0.00391	0.00391	CbGeAlD
Bosutinib—MERTK—female gonad—appendix cancer	0.0039	0.0039	CbGeAlD
Bosutinib—BLK—lymph node—appendix cancer	0.00389	0.00389	CbGeAlD
Bosutinib—ERBB4—endocrine gland—appendix cancer	0.00386	0.00386	CbGeAlD
Bosutinib—PHKG1—lymph node—appendix cancer	0.00385	0.00385	CbGeAlD
Bosutinib—CASK—lymph node—appendix cancer	0.00385	0.00385	CbGeAlD
Bosutinib—MAP4K4—female gonad—appendix cancer	0.00383	0.00383	CbGeAlD
Bosutinib—ROCK1—endocrine gland—appendix cancer	0.00381	0.00381	CbGeAlD
Bosutinib—EIF2AK1—lymph node—appendix cancer	0.00381	0.00381	CbGeAlD
Bosutinib—NUAK2—female gonad—appendix cancer	0.0038	0.0038	CbGeAlD
Bosutinib—BCR—female gonad—appendix cancer	0.0038	0.0038	CbGeAlD
Bosutinib—MAP3K12—female gonad—appendix cancer	0.00377	0.00377	CbGeAlD
Bosutinib—TXK—lymph node—appendix cancer	0.00373	0.00373	CbGeAlD
Bosutinib—BMPR2—endocrine gland—appendix cancer	0.0037	0.0037	CbGeAlD
Bosutinib—MAP2K1—female gonad—appendix cancer	0.0037	0.0037	CbGeAlD
Bosutinib—STK35—female gonad—appendix cancer	0.0037	0.0037	CbGeAlD
Bosutinib—FES—lymph node—appendix cancer	0.00369	0.00369	CbGeAlD
Bosutinib—VRK2—lymph node—appendix cancer	0.00369	0.00369	CbGeAlD
Bosutinib—CSK—female gonad—appendix cancer	0.00367	0.00367	CbGeAlD
Bosutinib—STK36—endocrine gland—appendix cancer	0.00367	0.00367	CbGeAlD
Bosutinib—CSNK1A1—female gonad—appendix cancer	0.00365	0.00365	CbGeAlD
Bosutinib—YES1—smooth muscle tissue—appendix cancer	0.00363	0.00363	CbGeAlD
Bosutinib—MERTK—endocrine gland—appendix cancer	0.00363	0.00363	CbGeAlD
Bosutinib—HCK—female gonad—appendix cancer	0.00363	0.00363	CbGeAlD
Bosutinib—CLK1—female gonad—appendix cancer	0.00363	0.00363	CbGeAlD
Bosutinib—SRC—epithelium—appendix cancer	0.00362	0.00362	CbGeAlD
Bosutinib—TNIK—lymph node—appendix cancer	0.00362	0.00362	CbGeAlD
Bosutinib—SYK—lymph node—appendix cancer	0.00362	0.00362	CbGeAlD
Bosutinib—ABL2—female gonad—appendix cancer	0.0036	0.0036	CbGeAlD
Bosutinib—CDK2—lymph node—appendix cancer	0.00358	0.00358	CbGeAlD
Bosutinib—MAP4K4—endocrine gland—appendix cancer	0.00356	0.00356	CbGeAlD
Bosutinib—BMP2K—female gonad—appendix cancer	0.00356	0.00356	CbGeAlD
Bosutinib—CAMK2G—female gonad—appendix cancer	0.00356	0.00356	CbGeAlD
Bosutinib—STK26—lymph node—appendix cancer	0.00355	0.00355	CbGeAlD
Bosutinib—BCR—endocrine gland—appendix cancer	0.00353	0.00353	CbGeAlD
Bosutinib—LRRK2—female gonad—appendix cancer	0.00353	0.00353	CbGeAlD
Bosutinib—EGFR—female gonad—appendix cancer	0.00352	0.00352	CbGeAlD
Bosutinib—MAP3K12—endocrine gland—appendix cancer	0.00351	0.00351	CbGeAlD
Bosutinib—SRC—smooth muscle tissue—appendix cancer	0.00349	0.00349	CbGeAlD
Bosutinib—MAP2K1—endocrine gland—appendix cancer	0.00344	0.00344	CbGeAlD
Bosutinib—STK35—endocrine gland—appendix cancer	0.00344	0.00344	CbGeAlD
Bosutinib—PTK2B—female gonad—appendix cancer	0.00344	0.00344	CbGeAlD
Bosutinib—CHEK2—lymph node—appendix cancer	0.00343	0.00343	CbGeAlD
Bosutinib—CSK—endocrine gland—appendix cancer	0.00342	0.00342	CbGeAlD
Bosutinib—WEE1—lymph node—appendix cancer	0.0034	0.0034	CbGeAlD
Bosutinib—DMPK—lymph node—appendix cancer	0.0034	0.0034	CbGeAlD
Bosutinib—CSNK1A1—endocrine gland—appendix cancer	0.00339	0.00339	CbGeAlD
Bosutinib—CSNK1E—female gonad—appendix cancer	0.00338	0.00338	CbGeAlD
Bosutinib—CLK1—endocrine gland—appendix cancer	0.00337	0.00337	CbGeAlD
Bosutinib—HCK—endocrine gland—appendix cancer	0.00337	0.00337	CbGeAlD
Bosutinib—SIK1—female gonad—appendix cancer	0.00333	0.00333	CbGeAlD
Bosutinib—IRAK4—female gonad—appendix cancer	0.00333	0.00333	CbGeAlD
Bosutinib—BMP2K—endocrine gland—appendix cancer	0.00331	0.00331	CbGeAlD
Bosutinib—CAMK2G—endocrine gland—appendix cancer	0.00331	0.00331	CbGeAlD
Bosutinib—EPHA4—female gonad—appendix cancer	0.0033	0.0033	CbGeAlD
Bosutinib—LRRK2—endocrine gland—appendix cancer	0.00328	0.00328	CbGeAlD
Bosutinib—ERBB3—female gonad—appendix cancer	0.00326	0.00326	CbGeAlD
Bosutinib—MAP2K2—female gonad—appendix cancer	0.00325	0.00325	CbGeAlD
Bosutinib—ULK3—female gonad—appendix cancer	0.00325	0.00325	CbGeAlD
Bosutinib—STK25—lymph node—appendix cancer	0.00325	0.00325	CbGeAlD
Bosutinib—MAP3K2—female gonad—appendix cancer	0.00323	0.00323	CbGeAlD
Bosutinib—EPHA3—lymph node—appendix cancer	0.00322	0.00322	CbGeAlD
Bosutinib—MAP3K7—female gonad—appendix cancer	0.0032	0.0032	CbGeAlD
Bosutinib—PTK2B—endocrine gland—appendix cancer	0.0032	0.0032	CbGeAlD
Bosutinib—PTK2—female gonad—appendix cancer	0.00316	0.00316	CbGeAlD
Bosutinib—TBK1—female gonad—appendix cancer	0.00316	0.00316	CbGeAlD
Bosutinib—PLK2—lymph node—appendix cancer	0.00316	0.00316	CbGeAlD
Bosutinib—CSNK1E—endocrine gland—appendix cancer	0.00314	0.00314	CbGeAlD
Bosutinib—SIK3—lymph node—appendix cancer	0.00314	0.00314	CbGeAlD
Bosutinib—CSF1R—smooth muscle tissue—appendix cancer	0.00313	0.00313	CbGeAlD
Bosutinib—IRAK1—female gonad—appendix cancer	0.0031	0.0031	CbGeAlD
Bosutinib—SIK1—endocrine gland—appendix cancer	0.0031	0.0031	CbGeAlD
Bosutinib—EPHA4—endocrine gland—appendix cancer	0.00306	0.00306	CbGeAlD
Bosutinib—RPS6KB1—female gonad—appendix cancer	0.00304	0.00304	CbGeAlD
Bosutinib—ERBB3—endocrine gland—appendix cancer	0.00303	0.00303	CbGeAlD
Bosutinib—MAP2K2—endocrine gland—appendix cancer	0.00303	0.00303	CbGeAlD
Bosutinib—ULK3—endocrine gland—appendix cancer	0.00303	0.00303	CbGeAlD
Bosutinib—LCK—female gonad—appendix cancer	0.00303	0.00303	CbGeAlD
Bosutinib—FGR—female gonad—appendix cancer	0.00303	0.00303	CbGeAlD
Bosutinib—STK4—lymph node—appendix cancer	0.00302	0.00302	CbGeAlD
Bosutinib—AXL—female gonad—appendix cancer	0.00301	0.00301	CbGeAlD
Bosutinib—MAP3K2—endocrine gland—appendix cancer	0.00301	0.00301	CbGeAlD
Bosutinib—CAMK1D—lymph node—appendix cancer	0.00298	0.00298	CbGeAlD
Bosutinib—STK24—lymph node—appendix cancer	0.00295	0.00295	CbGeAlD
Bosutinib—PTK2—endocrine gland—appendix cancer	0.00294	0.00294	CbGeAlD
Bosutinib—TBK1—endocrine gland—appendix cancer	0.00294	0.00294	CbGeAlD
Bosutinib—SLK—female gonad—appendix cancer	0.0029	0.0029	CbGeAlD
Bosutinib—PDGFRB—epithelium—appendix cancer	0.00288	0.00288	CbGeAlD
Bosutinib—EPHB4—female gonad—appendix cancer	0.00288	0.00288	CbGeAlD
Bosutinib—ALK—lymph node—appendix cancer	0.00285	0.00285	CbGeAlD
Bosutinib—FER—lymph node—appendix cancer	0.00285	0.00285	CbGeAlD
Bosutinib—RPS6KB1—endocrine gland—appendix cancer	0.00283	0.00283	CbGeAlD
Bosutinib—EPHA2—female gonad—appendix cancer	0.00283	0.00283	CbGeAlD
Bosutinib—FYN—female gonad—appendix cancer	0.00282	0.00282	CbGeAlD
Bosutinib—FGR—endocrine gland—appendix cancer	0.00281	0.00281	CbGeAlD
Bosutinib—AXL—endocrine gland—appendix cancer	0.0028	0.0028	CbGeAlD
Bosutinib—MAP4K1—lymph node—appendix cancer	0.0028	0.0028	CbGeAlD
Bosutinib—BTK—lymph node—appendix cancer	0.00278	0.00278	CbGeAlD
Bosutinib—PDGFRB—smooth muscle tissue—appendix cancer	0.00278	0.00278	CbGeAlD
Bosutinib—MAP3K3—female gonad—appendix cancer	0.00276	0.00276	CbGeAlD
Bosutinib—MAP4K5—female gonad—appendix cancer	0.00276	0.00276	CbGeAlD
Bosutinib—TNK2—lymph node—appendix cancer	0.00274	0.00274	CbGeAlD
Bosutinib—MAP4K2—lymph node—appendix cancer	0.0027	0.0027	CbGeAlD
Bosutinib—EPHB4—endocrine gland—appendix cancer	0.00268	0.00268	CbGeAlD
Bosutinib—STK3—lymph node—appendix cancer	0.00267	0.00267	CbGeAlD
Bosutinib—EPHA2—endocrine gland—appendix cancer	0.00263	0.00263	CbGeAlD
Bosutinib—FYN—endocrine gland—appendix cancer	0.00262	0.00262	CbGeAlD
Bosutinib—MAP4K5—endocrine gland—appendix cancer	0.00256	0.00256	CbGeAlD
Bosutinib—MAP3K3—endocrine gland—appendix cancer	0.00256	0.00256	CbGeAlD
Bosutinib—BMPR2—lymph node—appendix cancer	0.00256	0.00256	CbGeAlD
Bosutinib—YES1—female gonad—appendix cancer	0.00255	0.00255	CbGeAlD
Bosutinib—EPHB3—lymph node—appendix cancer	0.00254	0.00254	CbGeAlD
Bosutinib—STK36—lymph node—appendix cancer	0.00254	0.00254	CbGeAlD
Bosutinib—STK10—female gonad—appendix cancer	0.00252	0.00252	CbGeAlD
Bosutinib—TAOK3—female gonad—appendix cancer	0.00251	0.00251	CbGeAlD
Bosutinib—MERTK—lymph node—appendix cancer	0.00251	0.00251	CbGeAlD
Bosutinib—ABL1—smooth muscle tissue—appendix cancer	0.00248	0.00248	CbGeAlD
Bosutinib—MAP4K4—lymph node—appendix cancer	0.00246	0.00246	CbGeAlD
Bosutinib—SRC—female gonad—appendix cancer	0.00245	0.00245	CbGeAlD
Bosutinib—NUAK2—lymph node—appendix cancer	0.00244	0.00244	CbGeAlD
Bosutinib—BCR—lymph node—appendix cancer	0.00244	0.00244	CbGeAlD
Bosutinib—MAP3K12—lymph node—appendix cancer	0.00243	0.00243	CbGeAlD
Bosutinib—MAP2K1—lymph node—appendix cancer	0.00238	0.00238	CbGeAlD
Bosutinib—STK35—lymph node—appendix cancer	0.00238	0.00238	CbGeAlD
Bosutinib—YES1—endocrine gland—appendix cancer	0.00237	0.00237	CbGeAlD
Bosutinib—CSK—lymph node—appendix cancer	0.00236	0.00236	CbGeAlD
Bosutinib—STK10—endocrine gland—appendix cancer	0.00235	0.00235	CbGeAlD
Bosutinib—CSNK1A1—lymph node—appendix cancer	0.00235	0.00235	CbGeAlD
Bosutinib—TAOK3—endocrine gland—appendix cancer	0.00234	0.00234	CbGeAlD
Bosutinib—HCK—lymph node—appendix cancer	0.00233	0.00233	CbGeAlD
Bosutinib—CLK1—lymph node—appendix cancer	0.00233	0.00233	CbGeAlD
Bosutinib—ABL2—lymph node—appendix cancer	0.00232	0.00232	CbGeAlD
Bosutinib—CAMK2G—lymph node—appendix cancer	0.00229	0.00229	CbGeAlD
Bosutinib—BMP2K—lymph node—appendix cancer	0.00229	0.00229	CbGeAlD
Bosutinib—SRC—endocrine gland—appendix cancer	0.00228	0.00228	CbGeAlD
Bosutinib—LRRK2—lymph node—appendix cancer	0.00227	0.00227	CbGeAlD
Bosutinib—EGFR—lymph node—appendix cancer	0.00226	0.00226	CbGeAlD
Bosutinib—MAP2K5—female gonad—appendix cancer	0.00225	0.00225	CbGeAlD
Bosutinib—PTK2B—lymph node—appendix cancer	0.00221	0.00221	CbGeAlD
Bosutinib—CSF1R—female gonad—appendix cancer	0.0022	0.0022	CbGeAlD
Bosutinib—CSNK1E—lymph node—appendix cancer	0.00217	0.00217	CbGeAlD
Bosutinib—SIK1—lymph node—appendix cancer	0.00214	0.00214	CbGeAlD
Bosutinib—IRAK4—lymph node—appendix cancer	0.00214	0.00214	CbGeAlD
Bosutinib—EPHA4—lymph node—appendix cancer	0.00212	0.00212	CbGeAlD
Bosutinib—ERBB3—lymph node—appendix cancer	0.0021	0.0021	CbGeAlD
Bosutinib—MAP2K5—endocrine gland—appendix cancer	0.0021	0.0021	CbGeAlD
Bosutinib—ULK3—lymph node—appendix cancer	0.00209	0.00209	CbGeAlD
Bosutinib—MAP2K2—lymph node—appendix cancer	0.00209	0.00209	CbGeAlD
Bosutinib—MAP3K2—lymph node—appendix cancer	0.00208	0.00208	CbGeAlD
Bosutinib—MAP3K7—lymph node—appendix cancer	0.00206	0.00206	CbGeAlD
Bosutinib—CSF1R—endocrine gland—appendix cancer	0.00204	0.00204	CbGeAlD
Bosutinib—TBK1—lymph node—appendix cancer	0.00203	0.00203	CbGeAlD
Bosutinib—PTK2—lymph node—appendix cancer	0.00203	0.00203	CbGeAlD
Bosutinib—IRAK1—lymph node—appendix cancer	0.00199	0.00199	CbGeAlD
Bosutinib—RPS6KB1—lymph node—appendix cancer	0.00196	0.00196	CbGeAlD
Bosutinib—PDGFRB—female gonad—appendix cancer	0.00195	0.00195	CbGeAlD
Bosutinib—FGR—lymph node—appendix cancer	0.00195	0.00195	CbGeAlD
Bosutinib—LCK—lymph node—appendix cancer	0.00195	0.00195	CbGeAlD
Bosutinib—AXL—lymph node—appendix cancer	0.00194	0.00194	CbGeAlD
Bosutinib—SLK—lymph node—appendix cancer	0.00187	0.00187	CbGeAlD
Bosutinib—EPHB4—lymph node—appendix cancer	0.00185	0.00185	CbGeAlD
Bosutinib—EPHA2—lymph node—appendix cancer	0.00182	0.00182	CbGeAlD
Bosutinib—PDGFRB—endocrine gland—appendix cancer	0.00181	0.00181	CbGeAlD
Bosutinib—FYN—lymph node—appendix cancer	0.00181	0.00181	CbGeAlD
Bosutinib—MAP4K5—lymph node—appendix cancer	0.00177	0.00177	CbGeAlD
Bosutinib—MAP3K3—lymph node—appendix cancer	0.00177	0.00177	CbGeAlD
Bosutinib—ABL1—female gonad—appendix cancer	0.00174	0.00174	CbGeAlD
Bosutinib—YES1—lymph node—appendix cancer	0.00164	0.00164	CbGeAlD
Bosutinib—STK10—lymph node—appendix cancer	0.00162	0.00162	CbGeAlD
Bosutinib—ABL1—endocrine gland—appendix cancer	0.00162	0.00162	CbGeAlD
Bosutinib—TAOK3—lymph node—appendix cancer	0.00162	0.00162	CbGeAlD
Bosutinib—SRC—lymph node—appendix cancer	0.00157	0.00157	CbGeAlD
Bosutinib—MAP2K5—lymph node—appendix cancer	0.00145	0.00145	CbGeAlD
Bosutinib—CSF1R—lymph node—appendix cancer	0.00141	0.00141	CbGeAlD
Bosutinib—PDGFRB—lymph node—appendix cancer	0.00125	0.00125	CbGeAlD
Bosutinib—ABL1—lymph node—appendix cancer	0.00112	0.00112	CbGeAlD
Bosutinib—ABCB1—epithelium—appendix cancer	0.0008	0.0008	CbGeAlD
Bosutinib—CYP3A4—endocrine gland—appendix cancer	0.00071	0.00071	CbGeAlD
Bosutinib—ABCB1—female gonad—appendix cancer	0.00054	0.00054	CbGeAlD
Bosutinib—ABCB1—endocrine gland—appendix cancer	0.000503	0.000503	CbGeAlD
Bosutinib—ABCB1—lymph node—appendix cancer	0.000347	0.000347	CbGeAlD
